Invention Grant
- Patent Title: Glucagon-like peptide-2 analogs
-
Application No.: US12816312Application Date: 2010-06-15
-
Publication No.: US08933039B2Publication Date: 2015-01-13
- Inventor: Daniel J Drucker , Anna E. Crivici , Martin Sumner-Smith
- Applicant: Daniel J Drucker , Anna E. Crivici , Martin Sumner-Smith
- Applicant Address: US NJ Bedminster CA
- Assignee: NPS Pharmaceuticals, Inc.,1149336 Ontario Inc.
- Current Assignee: NPS Pharmaceuticals, Inc.,1149336 Ontario Inc.
- Current Assignee Address: US NJ Bedminster CA
- Agency: Stoel Rives LLP
- Main IPC: C07K14/00
- IPC: C07K14/00 ; A61K38/16 ; A61K38/26 ; A61K35/37 ; C07K14/605 ; G01N33/483 ; A61K38/00
Abstract:
Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
Public/Granted literature
- US20110009320A1 GLUCAGON-LIKE PEPTIDE-2 ANALOGS Public/Granted day:2011-01-13
Information query
